ArticleCureus2026
Neurosarcoidosis Presenting With Cerebellar Hemorrhage and Spinal Cord Involvement: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurosarcoidosis is a rare manifestation of sarcoidosis, a systemic granulomatous disease. It presents a diagnostic challenge due to its varied clinical and radiologic features. We describe a 37-year-old male with biopsy-proven pulmonary sarcoidosis who developed progressive neurological symptoms, including dizziness, imbalance, diplopia, and lower extremity weakness. MRI revealed diffuse leptomeningeal enhancement, cervical spinal cord lesions, and left cerebellar hemorrhage with surrounding vasogenic edema, a relatively rare finding in neurosarcoidosis. Cerebrospinal fluid (CSF) analysis showed inflammatory changes, and mediastinal lymph node biopsy confirmed non-necrotizing granulomas. The patient was treated with high-dose corticosteroids followed by immunosuppressive therapy, leading to gradual improvement in gait and strength. This case highlights the importance of recognizing neurosarcoidosis as a potential cause of central nervous system hemorrhage. Cerebrovascular involvement, particularly intracerebral hemorrhage, is underrecognized but can have serious consequences, making early diagnosis and aggressive immunosuppressive therapy critical in preventing long-term neurological deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.